Theravance Biopharma (TBPH) Tax Rate (2014 - 2026)
Theravance Biopharma (TBPH) reported Tax Rate of 23.18% for Q1 2026, up 1923.0% year-over-year from 1.15% in Q1 2025, and up 134.74% quarter-over-quarter from 66.73% in Q4 2025.
Theravance Biopharma (TBPH) Tax Rate (2014 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 13 years of Tax Rate data on file, last reported at 23.18% in Q1 2026.
- Tax Rate for Q1 2026 came in at 23.18%, up 1923.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 118.99% (up 113850.0% YoY), and the FY2025 annual result was 167.19%, down 79492.0% from the prior year.
- Tax Rate rose to 23.18% in Q1 2026 per TBPH's latest filing, from 66.73% in the prior quarter.
- Over five years, Tax Rate peaked at 224.99% in Q3 2025 and troughed at 69.18% in Q4 2023.
- A 5-year average of 6.3% and a median of 0.02% in 2022 frame the typical range for Tax Rate.
- On a YoY basis, Tax Rate climbed as much as 25131 bps in 2025 and fell as far as 10431 bps in 2025.
- A 5-year view of Tax Rate shows it stood at 0.02% in 2022, then slumped by 328906 bps to 69.18% in 2023, then jumped by 154 bps to 37.57% in 2024, then plunged by 278 bps to 66.73% in 2025, then soared by 135 bps to 23.18% in 2026.
- Business Quant data shows TBPH's Tax Rate at 23.18% in Q1 2026, 66.73% in Q4 2025, and 224.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 5.61% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Theravance Biopharma | 835.85 Mn | 441.18 Mn | - | 23.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.18% |
| Mar 31, 2026 | 23.18% |
| Dec 31, 2025 | -66.73% |
| Dec 31, 2025 | -66.73% |
| Sep 30, 2025 | 224.99% |
| Sep 30, 2025 | 224.99% |
| Jun 30, 2025 | 25.09% |
| Jun 30, 2025 | 25.09% |
| Mar 31, 2025 | 3.95% |
| Mar 31, 2025 | 3.95% |
| Dec 31, 2024 | 37.57% |
| Dec 31, 2024 | 37.57% |
| Sep 30, 2024 | -26.32% |
| Sep 30, 2024 | -26.32% |
| Jun 30, 2024 | -8.59% |
| Jun 30, 2024 | -8.59% |
| Mar 31, 2024 | -12.13% |
| Mar 31, 2024 | -12.13% |
| Dec 31, 2023 | -69.18% |
| Dec 31, 2023 | -69.18% |